Full Press Release Details
The Investor Presentation of Celsion Corporation is contained in the corresponding .PDF File.
IMNN
The Investor Presentation of Celsion Corporation is contained in the corresponding .PDF File.
Key Takeaway: The Investor Presentation of Celsion Corporation is contained in the corresponding .PDF File.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+9%
120-day peak, hindsight
Typical move
8.5%
average across 10 past catalysts
Cash runway
~7 mo
Medium dilution risk
Lead asset
pegylated liposomal doxorubicin
Phase 1 · Prostate Cancer